Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Tooth, Impacted 1Sleep Initiation and Maintenance Disorders 1Resectable Colorectal Carcinoma 1Nocturia 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Agnosia 1

Interventions

Rituximab 21Cyclophosphamide 21fludarabine 12fludarabine phosphate 10pirtobrutinib 6obinutuzumab 6ibrutinib 6acalabrutinib 6Tacrolimus 6Mycophenolic Acid 6Melphalan 6Magnetic Resonance Spectroscopy 6Biopsy 6venetoclax 5tocilizumab 5X-Rays 5Whole-Body Irradiation 5Specimen Handling 5Prednisone 5Phantoms, Imaging 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Etoposide 5Doxorubicin 5Thiotepa 4Lenalidomide 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Cytarabine 4Bendamustine Hydrochloride 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lymphoma, Non-Hodgkin × Acupuncture Therapy × Clear all
NCT04459416 2025-10-20

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
299 enrolled 11 charts
LymphoidPlasma cell

Agnosia, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡